FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950058512> ?p ?o ?g. }

• W2950058512 endingPage "227" @default.
• W2950058512 startingPage "216" @default.
• W2950058512 abstract "Alzheimer's disease (AD) pathology, including the accumulation of amyloid beta (Aβ) species and tau pathology, begins decades before the onset of cognitive impairment. This long preclinical period provides an opportunity for clinical trials designed to prevent or delay the onset of cognitive impairment due to AD. Under the umbrella of the Alzheimer's Prevention Initiative Generation Program, therapies targeting Aβ, including CNP520 (umibecestat), a β-site-amyloid precursor protein cleaving enzyme-1 (BACE-1) inhibitor, and CAD106, an active Aβ immunotherapy, are in clinical development in preclinical AD.The Alzheimer's Prevention Initiative Generation Program comprises two pivotal (phase 2/3) studies that assess the efficacy and safety of umibecestat and CAD106 in cognitively unimpaired individuals with high risk for developing symptoms of AD based on their age (60-75 years), APOE4 genotype, and, for heterozygotes (APOE ε2/ε4 or ε3/ε4), elevated brain amyloid. Approximately, 3500 individuals will be enrolled in either Generation Study 1 (randomized to cohort 1 [CAD106 injection or placebo, 5:3] or cohort 2 [oral umibecestat 50 mg or placebo, 3:2]) or Generation Study 2 (randomized to oral umibecestat 50 mg and 15 mg, or placebo [2:1:2]). Participants receive treatment for at least 60 months and up to a maximum of 96 months. Primary outcomes include time to event, with event defined as diagnosis of mild cognitive impairment due to AD and/or dementia due to AD, and the Alzheimer's Prevention Initiative preclinical composite cognitive test battery. Secondary endpoints include the Clinical Dementia Rating Sum of Boxes, Repeatable Battery for the Assessment of Neuropsychological Status total score, Everyday Cognition Scale, biomarkers, and brain imaging.The Generation Program is designed to assess the efficacy, safety, and biomarker effects of the two treatments in individuals at high risk for AD. It may also provide a plausible test of the amyloid hypothesis and further accelerate the evaluation of AD prevention therapies." @default.
• W2950058512 created "2019-06-27" @default.
• W2950058512 creator A5002451678 @default.
• W2950058512 creator A5006222462 @default.
• W2950058512 creator A5009988073 @default.
• W2950058512 creator A5013689065 @default.
• W2950058512 creator A5019125757 @default.
• W2950058512 creator A5019701878 @default.
• W2950058512 creator A5024602962 @default.
• W2950058512 creator A5030422861 @default.
• W2950058512 creator A5040374029 @default.
• W2950058512 creator A5041363249 @default.
• W2950058512 creator A5046645678 @default.
• W2950058512 creator A5047768726 @default.
• W2950058512 creator A5067634007 @default.
• W2950058512 creator A5073489682 @default.
• W2950058512 creator A5077535265 @default.
• W2950058512 creator A5086970155 @default.
• W2950058512 date "2019-01-01" @default.
• W2950058512 modified "2023-10-18" @default.
• W2950058512 title "The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease" @default.
• W2950058512 cites W1622703765 @default.
• W2950058512 cites W1644143258 @default.
• W2950058512 cites W1832723368 @default.
• W2950058512 cites W1972773714 @default.
• W2950058512 cites W1973798645 @default.
• W2950058512 cites W1986144956 @default.
• W2950058512 cites W1989820287 @default.
• W2950058512 cites W2015484447 @default.
• W2950058512 cites W2019528205 @default.
• W2950058512 cites W2023121717 @default.
• W2950058512 cites W2031331450 @default.
• W2950058512 cites W2046182783 @default.
• W2950058512 cites W2052784798 @default.
• W2950058512 cites W2058161128 @default.
• W2950058512 cites W2063808031 @default.
• W2950058512 cites W2066358461 @default.
• W2950058512 cites W2086572083 @default.
• W2950058512 cites W2097247234 @default.
• W2950058512 cites W2107094473 @default.
• W2950058512 cites W2111883386 @default.
• W2950058512 cites W2115017507 @default.
• W2950058512 cites W2115300091 @default.
• W2950058512 cites W2129497119 @default.
• W2950058512 cites W2131328232 @default.
• W2950058512 cites W2135780456 @default.
• W2950058512 cites W2136250824 @default.
• W2950058512 cites W2139852500 @default.
• W2950058512 cites W2140718540 @default.
• W2950058512 cites W2148080316 @default.
• W2950058512 cites W2148083007 @default.
• W2950058512 cites W2152446053 @default.
• W2950058512 cites W2154125779 @default.
• W2950058512 cites W2168357345 @default.
• W2950058512 cites W2169096667 @default.
• W2950058512 cites W2171346860 @default.
• W2950058512 cites W2171811563 @default.
• W2950058512 cites W2268467116 @default.
• W2950058512 cites W2329336071 @default.
• W2950058512 cites W2346833359 @default.
• W2950058512 cites W2510806376 @default.
• W2950058512 cites W2516870772 @default.
• W2950058512 cites W2565340265 @default.
• W2950058512 cites W2582524520 @default.
• W2950058512 cites W2600450442 @default.
• W2950058512 cites W2767538090 @default.
• W2950058512 cites W2787612390 @default.
• W2950058512 cites W2789516300 @default.
• W2950058512 cites W2802659348 @default.
• W2950058512 cites W2890206141 @default.
• W2950058512 doi "https://doi.org/10.1016/j.trci.2019.02.005" @default.
• W2950058512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6562315" @default.
• W2950058512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31211217" @default.
• W2950058512 hasPublicationYear "2019" @default.
• W2950058512 type Work @default.
• W2950058512 sameAs 2950058512 @default.
• W2950058512 citedByCount "77" @default.
• W2950058512 countsByYear W29500585122019 @default.
• W2950058512 countsByYear W29500585122020 @default.
• W2950058512 countsByYear W29500585122021 @default.
• W2950058512 countsByYear W29500585122022 @default.
• W2950058512 countsByYear W29500585122023 @default.
• W2950058512 crossrefType "journal-article" @default.
• W2950058512 hasAuthorship W2950058512A5002451678 @default.
• W2950058512 hasAuthorship W2950058512A5006222462 @default.
• W2950058512 hasAuthorship W2950058512A5009988073 @default.
• W2950058512 hasAuthorship W2950058512A5013689065 @default.
• W2950058512 hasAuthorship W2950058512A5019125757 @default.
• W2950058512 hasAuthorship W2950058512A5019701878 @default.
• W2950058512 hasAuthorship W2950058512A5024602962 @default.
• W2950058512 hasAuthorship W2950058512A5030422861 @default.
• W2950058512 hasAuthorship W2950058512A5040374029 @default.
• W2950058512 hasAuthorship W2950058512A5041363249 @default.
• W2950058512 hasAuthorship W2950058512A5046645678 @default.
• W2950058512 hasAuthorship W2950058512A5047768726 @default.
• W2950058512 hasAuthorship W2950058512A5067634007 @default.
• W2950058512 hasAuthorship W2950058512A5073489682 @default.
• W2950058512 hasAuthorship W2950058512A5077535265 @default.

• next